Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Ascendis Pharma AS’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 28 Nov 2023 | Teijin Enters into Licensing Agreement with Ascendis Pharma | Licensing Agreement |
Teijin Limited Tokyo
|
Ascendis Pharma AS |
| 23 Mar 2022 | Ascendis Pharma Raises USD575 Million in Private Placement of 2.25% Convertible Senior Notes Due 2028 | Debt Offering | - |
Ascendis Pharma AS |
| 02 Feb 2022 | Pharma-Q to Acquire 51% Stake in Ascendis Pharma | Acquisition |
Pharma-Q Pty Ltd
|
Ascendis Pharma AS |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer